Point72 Middle East Fze Allogene Therapeutics, Inc. Transaction History

Point72 Middle East Fze

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$2.28 - $3.5 $290,100 - $445,329
127,237 New
127,237 $408,000
Q2 2023

Aug 14, 2023
BUY
$4.53 - $6.74 $207,650 - $308,954
45,839 Added 545.51%
54,242 $269,000
Q1 2023

May 15, 2023
SELL
$4.92 - $8.21 $235,259 - $392,577
-47,817 Reduced 85.05%
8,403 $41,000
Q4 2022

Feb 14, 2023
BUY
$5.62 - $11.11 $315,956 - $624,604
56,220 New
56,220 $0

Others Institutions Holding ALLO

# of Institutions
162
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $326M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Point72 Middle East Fze Portfolio

Follow Point72 Middle East Fze and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Middle East Fze with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email